These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38622535)

  • 1. Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.
    Yeh YK; Lin KH; Sheu WH; Lo SH; Yeh YP; Huang CN; Hwu CM; Lu CH
    BMC Nephrol; 2024 Apr; 25(1):133. PubMed ID: 38622535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
    Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W
    Front Public Health; 2022; 10():1047794. PubMed ID: 36420005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
    Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T
    Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.
    Kaze AD; Jaar BG; Fonarow GC; Echouffo-Tcheugui JB
    BMC Med; 2022 Mar; 20(1):127. PubMed ID: 35346165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
    JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
    Rossing P; Groehl F; Mernagh P; Folkerts K; Garreta-Rufas A; Harris J; Meredith K; Carter M; Åkerborg Ö; Wanner C; Hobbs FDR
    J Med Econ; 2023; 26(1):935-943. PubMed ID: 37439218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study.
    Fraser SD; Parkes J; Culliford D; Santer M; Roderick PJ
    BMC Fam Pract; 2015 Feb; 16():18. PubMed ID: 25879207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations.
    Stempniewicz N; Vassalotti JA; Cuddeback JK; Ciemins E; Storfer-Isser A; Sang Y; Matsushita K; Ballew SH; Chang AR; Levey AS; Bailey RA; Fishman J; Coresh J
    Diabetes Care; 2021 Sep; 44(9):2000-2009. PubMed ID: 34233925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
    Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
    Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk.
    Verhagen C; Janssen J; Minderhoud CA; van den Berg E; Wanner C; Passera A; Johansen OE; Biessels GJ
    J Diabetes Complications; 2022 Oct; 36(10):108303. PubMed ID: 36116359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Betts KA; Song J; Elliott J; Warnock N; Farej R; Wu A; Singh R
    Am J Manag Care; 2022 Aug; 28(6 Suppl):S112-S119. PubMed ID: 35997775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.